Related Experiment Video
Updated: Apr 26, 2026
05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
11.9K
New problems arising from old drugs: second-generation effects of acetaminophen
Gisa Tiegs1, Khalil Karimi, Kay Brune
1Institute of Experimental Immunology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Expert Review of Clinical Pharmacology
|July 31, 2014
Summary
Acetaminophen (APAP) is safe in recommended doses, but overdose causes liver failure. Prenatal APAP exposure may increase asthma risk in offspring.
Area of Science:
- Pharmacology
- Toxicology
- Epidemiology
Background:
- Acetaminophen (APAP), a widely used analgesic and antipyretic, is generally safe at recommended doses.
- However, APAP overdose is a leading cause of acute liver failure (ALF), necessitating transplantation and posing a mortality risk.
- Emerging evidence suggests potential adverse effects of APAP, even at therapeutic doses, particularly concerning second-generation health outcomes.
Purpose of the Study:
- To review epidemiological findings on APAP exposure during pregnancy.
- To investigate the molecular and cellular mechanisms underlying APAP-associated prenatal risks for asthma in offspring.
Main Methods:
- Review of large-scale epidemiological studies.
- Analysis of molecular and cellular mechanisms.
Main Results:
- Prenatal exposure to APAP has been linked to neurodevelopmental and behavioral issues in offspring, including ADHD.
- Increased risk of wheezing and asthma incidence has been observed in children exposed to APAP in utero.
- The study aims to elucidate the biological pathways mediating these prenatal risks.
Conclusions:
- While APAP is a common medication, its use during pregnancy warrants careful consideration due to potential long-term health consequences for offspring.
- Further research into the mechanisms of APAP's teratogenic effects is crucial for understanding and mitigating risks.
- Understanding these mechanisms can inform clinical guidelines and public health strategies regarding APAP use in pregnant individuals.
Keywords:
asthmachildhood asthmafetal developmentimmune adaptation to pregnancyparacetamolpregnancyprenatal acetaminophen exposureMore Related Videos
Related Concept Videos
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
93
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
93
01:24Drug Toxicity: Dose-Dependent Reactions
229
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
01:24Phase II Reactions: Acetylation Reactions
1.1K
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
1.1K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
405
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
1.3K
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.3K